Metabolism - Clinical and Experimental
Volume 46, Issue 7 , Pages 735-739, July 1997

Elevated serum lipoprotein(a) levels in young women with endometriosis

  • David Crook

      Affiliations

    • Corresponding Author InformationAddress reprint requests to David Crook, PhD, Wynn Division of Metabolic Medicine, 21 Wellington Rd, St John's Wood, London NW8 9SQ, England.
    • Wynn Division of Metabolic Medicine, Imperial College School of Medicine at the National Heart and Lung Institute, London, England
    • Department of Obstetrics and Gynaecology, Queen Charlotte's and Chelsea Hospital, London, England
  • ,
  • Rosemary Howell

      Affiliations

    • Wynn Division of Metabolic Medicine, Imperial College School of Medicine at the National Heart and Lung Institute, London, England
    • Department of Obstetrics and Gynaecology, Queen Charlotte's and Chelsea Hospital, London, England
  • ,
  • Mandeep Sidhu

      Affiliations

    • Wynn Division of Metabolic Medicine, Imperial College School of Medicine at the National Heart and Lung Institute, London, England
    • Department of Obstetrics and Gynaecology, Queen Charlotte's and Chelsea Hospital, London, England
  • ,
  • D.Keith Edmonds

      Affiliations

    • Wynn Division of Metabolic Medicine, Imperial College School of Medicine at the National Heart and Lung Institute, London, England
    • Department of Obstetrics and Gynaecology, Queen Charlotte's and Chelsea Hospital, London, England
  • ,
  • John C. Stevenson

      Affiliations

    • Wynn Division of Metabolic Medicine, Imperial College School of Medicine at the National Heart and Lung Institute, London, England
    • Department of Obstetrics and Gynaecology, Queen Charlotte's and Chelsea Hospital, London, England

Received 23 October 1995; accepted 1 August 1996.

Abstract 

Elevated serum lipoportein(a) [Lp(a)] levels increase the risk of cardiovacsular disease if levels of low-density lipoproteins (LDLs) are also high. The biological function of Lp(a) is unknown, but plasma levels may be elevated in inflammatory disease. Endometriosis is a common gynecologic disorder in which endometrial tissue is found outside of the lining of the uterine cavity. There is an immune component to this condition whereby the number of peritoneal macrophages is increased and the level of prostanoids and cytokines in peritoneal fluid is elevated. In the present study, we measured serum lipid, lipoprotein, and apolipoprotein levels in 29 women with endometriosis and in 29 matched healthy controls. Fasting serum triglyceride and apolipoprotein (apo) AI levels were higher in women with endometriosis (+28.1%, P < .001, and +12.3%, P < .01, respectively), but there were no significant differences in LDL or high-density lipoprotein (HDL) cholesterol levels. Serum Lp(a) levels were fivefold higher (P < .01) in the patients (median, 15.0 mg/dL; range, 0.05 to 60.0) than in controls (median, 3.1 mg/dL; range, 0.05 to 57.2). The distribution of apo(a) isoforms was similar in the two groups, but in women with endometriosis the individual apo(a) isoforms tended to be associated with higher serum Lp(a) levels. Endometriosis may represent a relatively common condition in which to investigate the role of Lp(a) in human metabolism.

No full text is available. To read the body of this article, please view the PDF online.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Supported by British United Provident Association Medical Foundation, the Heart Disease and Diabetes Research Trust, and the Cecil Rosen Foundation, London, England.

PII: S0026-0495(97)90115-3

Metabolism - Clinical and Experimental
Volume 46, Issue 7 , Pages 735-739, July 1997